TREM2 and Alzheimer disease: As mutants that increase AD risk seem to have a partial loss of TREM2 function, and considering that overexpression studies with TREM2 seem to enhance its function in processes associated with AD (Takahashi et al., 2005; Lee et al., 2018), one hypothesis is that augmenting the amount or function of TREM2 might oppose AD progression.